ScholarIQanswers from OpenAlex

Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro

PaperCitations, authors & open-access status

Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro have?

ScholarIQcitation count

Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro has 149 citations in the OpenAlex counts ScholarIQ stores.

When was Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro published?

ScholarIQyear

Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro has 2011 year in the ScholarIQ index.

What is the open-access status of Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro?

ScholarIQoa status

Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro has closed oa status in the ScholarIQ index.

What is the DOI of Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro?

ScholarIQdoi

The DOI for Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro is on the source record.

What is the PMID of Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro?

ScholarIQpmid

The PMID for Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro is on the source record.

What is the OpenAlex record for Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro?

ScholarIQopenalex

The OpenAlex for Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial